Cargando…
A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs
Background: Preclinical cell models are the mainstay in the early stages of drug development. We sought to explore the preclinical data that differentiated successful from failed therapeutic agents in lung cancer. Methods: One hundred thirty-four failed lung cancer drugs and twenty seven successful...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190806/ https://www.ncbi.nlm.nih.gov/pubmed/32391273 http://dx.doi.org/10.3389/fonc.2020.00591 |